CAS: 55557-01-2 - 1,2,5,6-Tetrahydro-1-nitroso-3-pyridinecarboxylic acid
Formula:C6H8N2O3
InChI:InChI=1S/C6H8N2O3/c9-6(10)5-2-1-3-8(4-5)7-11/h2H,1,3-4H2,(H,9,10)
InChI key:InChIKey=XAZBVEFQMFZFEZ-UHFFFAOYSA-N
SMILES:O=NN1CC(=CCC1)C(=O)O
- Synonyms:
- N-Nitrosoguvacine
- 1-Nitroso-1,2,5,6-tetrahydropyridine-3-carboxylic acid
- 3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-nitroso-
- 1,2,5,6-Tetrahydro-1-nitroso-3-pyridinecarboxylic acid
- Nitrosoguvacine
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-Nitroso Guvacine REF: 4Z-G-224007CAS: 55557-01-2 | - - - | To inquire | Tue 10 Dec 24 |
 | N-Nitrosoguvacine REF: TR-N527615CAS: 55557-01-2 | - - - | 244.00 €~461.00 € | Tue 17 Dec 24 |
| N-Nitrosoguvacine-2,2,5,5-D4 REF: TR-N527617CAS: 55557-01-2 | - - - | 3,559.00 € | Fri 17 Jan 25 |
 | N-Nitrosoguvacine REF: 3D-FCA55701CAS: 55557-01-2 | Min. 95% | To inquire | Tue 21 Jan 25 |
| N-Nitroso Guvacine REF: 4Z-N-092007CAS: 55557-01-2 | - - - | - - - | Discontinued product |
Ref: 4Z-G-224007
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
N-Nitrosoguvacine
CAS:55557-01-2
Applications N-Nitrosoguvacine is a carcinogenic agent shown as a causative agent for oral cancer. An …
Formula:
C6H8N2O3
Color and Shape:
Off White Solid
Molecular weight:
156.14
Ref: TR-N527615
| 5mg | 244.00 € | ||
| 10mg | 461.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
N-Nitrosoguvacine-2,2,5,5-D4
Controlled ProductCAS:55557-01-2
Formula:
C6D4H4N2O3
Color and Shape:
Neat
Molecular weight:
160.164
Ref: TR-N527617
| 25mg | 3,559.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
N-Nitrosoguvacine
CAS:55557-01-2
N-Nitrosoguvacine is a genotoxic carcinogen that is used for the treatment of cancer. It is …
Formula:
C6H8N2O3
Purity:
Min. 95%
Molecular weight:
156.14 g/mol
Ref: 3D-FCA55701
| 50mg | 179.00 € | ||
| 500mg | 715.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 4Z-N-092007
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
